Russell D. Cohen to Risk Assessment
This is a "connection" page, showing publications Russell D. Cohen has written about Risk Assessment.
Connection Strength
0.211
-
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary. Gastroenterology. 2020 Jul; 159(1):350-357.
Score: 0.107
-
MLN-02 in IBD: is "super-selective" really super? Gastroenterology. 2006 May; 130(6):1923-4.
Score: 0.041
-
Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease. Gastrointest Endosc. 2019 08; 90(2):269-275.
Score: 0.025
-
Drug therapies and the risk of malignancy in Crohn's disease: results from the TREATâ„¢ Registry. Am J Gastroenterol. 2014 Feb; 109(2):212-23.
Score: 0.017
-
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol. 2006 May; 4(5):621-30.
Score: 0.010
-
Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002. Curr Med Res Opin. 2006 May; 22(5):989-1000.
Score: 0.010